ClinicalTrials.gg
CompletedNCT00330785JEWEL IUpdated Jan 27, 2021

Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and Dyslipidaemia

A Phase 3 interventional study of Amlodipine/Atorvastatin in Hypertension and Dyslipidemia, sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris Inc.. Completed at 126 sites in 2 countries. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2021-01-27.

Sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (part of Viatris Inc.) · Phase 3, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Enrollment
1,250
Allocation
Non-randomized
Ages
18 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-19

Among 187 studies testing amlodipine in Hypertension — 6 open to participants now, 8 under way, 2 of them phase 3. Amlodipine · Hypertension.

Enrollment
18th of 186
1,250 · median 180
Started
2004
with 13 others
Phase 3
69 of 187
2 open now
Registered
21st of 187
by date
Lead sponsor
6 of 187
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Among the 187 studies testing amlodipine in Hypertension, this one is the 18th largest by enrollment of the 186 interventional ones that give a count, is one of 14 that started in 2004, is one of 69 in phase 3, and was the 21st registered.

Hypertension

6,128 studies on the registry are indexed under Hypertension; 911 are open to participants now.

Browse Hypertension studies →

Open to participants now

6 of the 187 studies testing amlodipine in Hypertension are open now, in 4 countries. Recruiting first, the newest first:

1 more — sign in →

By country, each count listing its studies:

All 6 open studies →

About amlodipine

Amlodipine: first FDA approval 1992 (NORVASC), first EMA approval 2007. What it is approved for, and how studies give it, is on its page →

Who these studies take

Of the 556 Hypertension studies recruiting now, 262 (47%) set no upper age limit and 198 (36%) stop at 75 or younger; 40 take children under 18; 137 take healthy volunteers.

This study: 18 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 187 studies testing amlodipine in Hypertension, or all of them as a file.
02

Study summary

To evaluate the effectiveness of amlodipine/atorvastatin therapy by assessing the percentage of subjects who reach target blood pressure (BP) and LDL-C targets as defined by their governing guidelines.

03

Conditions studied

  • Hypertension
  • Dyslipidemia
04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients who are above target LDL-C and BP who are eligible for treatment

Exclusion criteria

Exclusion Criteria:

  • High liver enzymes
05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
1,250 participants

Interventions

06

What researchers measure

Primary outcomes

  1. To evaluate the number of patients who reach target blood pressure (BP) and

  2. LDL-C targets as defined by their governing guidelines.

Secondary outcomes

  1. To assess changes from baseline to end of treatment for the following efficacy

  2. parameters: LDL-C, total cholesterol (TC), triglycerides, high-density lipoprotein

  3. cholesterol (HDL-C), HDL-C/LDL-C ratio, TC/HDL-C ratio. Systolic Blood Pressure

  4. (SBP) and Diastolic Blood Pressue (DBP).

07

Study locations

126 sites
  • Pfizer Investigational Site
    Calgary, Alberta T2N 2T8, Canada
  • Pfizer Investigational Site
    Calgary, Alberta T2N 4N1, Canada
  • Pfizer Investigational Site
    Calgary, Alberta T2S 3C3, Canada
  • Pfizer Investigational Site
    Calgary, Alberta T2X 3X7, Canada
  • Pfizer Investigational Site
    Calgary, Alberta T3E 7C4, Canada
  • Pfizer Investigational Site
    Red Deer, Alberta T4R 3J5, Canada
  • Pfizer Investigational Site
    Campbell River, British Columbia V9W 5Y4, Canada
  • Pfizer Investigational Site
    Chilliwack, British Columbia V2P 4M9, Canada
  • Pfizer Investigational Site
    New Westminster, British Columbia V3L 3W4, Canada
  • Pfizer Investigational Site
    North Vancouver, British Columbia V7N 4M2, Canada
  • Pfizer Investigational Site
    Quesnel, British Columbia V2J 2K3, Canada
  • Pfizer Investigational Site
    Vancouver, British Columbia V5K 1K3, Canada
  • Pfizer Investigational Site
    Vancouver, British Columbia V5P 3T7, Canada
  • Pfizer Investigational Site
    Vancouver, British Columbia V5Z 4E1, Canada
  • Pfizer Investigational Site
    Vancouver, British Columbia V6J 1Z6, Canada
  • Pfizer Investigational Site
    Vancouver, British Columbia V6M 3W7, Canada
  • Pfizer Investigational Site
    Winnipeg, Manitoba R2H 0R8, Canada
  • Pfizer Investigational Site
    Winnipeg, Manitoba R3A 1R9, Canada
  • Pfizer Investigational Site
    Antigonish, Nova Scotia B2G 2C2, Canada
  • Pfizer Investigational Site
    Digby, Nova Scotia B0V 1A0, Canada
  • Pfizer Investigational Site
    Halifax, Nova Scotia B3H 1V7, Canada
  • Pfizer Investigational Site
    Halifax, Nova Scotia B3K 5R3, Canada
  • Pfizer Investigational Site
    Truro, Nova Scotia B2N 1L2, Canada
  • Pfizer Investigational Site
    Wolfville, Nova Scotia B4P 1P4, Canada
  • Pfizer Investigational Site
    Alymer, Ontario N5H 1K9, Canada
  • Pfizer Investigational Site
    Corunna, Ontario N0N 1G0, Canada
  • Pfizer Investigational Site
    Exeter, Ontario, Canada
  • Pfizer Investigational Site
    Hamilton, Ontario L8M 1K7, Canada
  • Pfizer Investigational Site
    Kingston, Ontario K7L 1C2, Canada
  • Pfizer Investigational Site
    London, Ontario N5W 1H4, Canada
  • Pfizer Investigational Site
    London, Ontario N5W 6A2, Canada
  • Pfizer Investigational Site
    London, Ontario N6A 4G5, Canada
  • Pfizer Investigational Site
    London, Ontario N6C 4Y7, Canada
  • Pfizer Investigational Site
    London, Ontario N6G 5A5, Canada
  • Pfizer Investigational Site
    London, Ontario N6H 4P2, Canada
  • Pfizer Investigational Site
    London, Ontario N6P 1A9, Canada
  • Pfizer Investigational Site
    North York, Ontario M2J 1W8, Canada
  • Pfizer Investigational Site
    North York, Ontario M3N 2V6, Canada
  • Pfizer Investigational Site
    Oshawa, Ontario L1H 1C5, Canada
  • Pfizer Investigational Site
    Oshawa, Ontario L1J 2K1, Canada
  • Pfizer Investigational Site
    Peterborough, Ontario K9H 5G1, Canada
  • Pfizer Investigational Site
    Sarnia, Ontario N7T 4X3, Canada
  • Pfizer Investigational Site
    Toronto, Ontario M4N 3M5, Canada
  • Pfizer Investigational Site
    Toronto, Ontario M4S 1Y2, Canada
  • Pfizer Investigational Site
    Toronto, Ontario M5G 2C4, Canada
  • Pfizer Investigational Site
    Toronto, Ontario M5T 3A9, Canada
  • Pfizer Investigational Site
    Waterloo, Ontario N2J 1C4, Canada
  • Pfizer Investigational Site
    Weston, Ontario M9N 1W4, Canada
  • Pfizer Investigational Site
    Whitby, Ontario L1N 5R5, Canada
  • Pfizer Investigational Site
    Charlottetown, Prince Edward Island C1A 5N4, Canada
  • Pfizer Investigational Site
    Bonaventure, Quebec GOC 1E0, Canada
  • Pfizer Investigational Site
    Chomedy, Quebec H7T 2P5, Canada
  • Pfizer Investigational Site
    Gatineau, Quebec J8Y 6S9, Canada
  • Pfizer Investigational Site
    Granby, Quebec J2G 8Z9, Canada
  • Pfizer Investigational Site
    Longueuil, Quebec J4N 1E1, Canada
  • Pfizer Investigational Site
    Montreal, Quebec H1T 1C8, Canada
  • Pfizer Investigational Site
    Montreal, Quebec H3T 1E2, Canada
  • Pfizer Investigational Site
    Pointe-Claire, Quebec H9R 4S3, Canada
  • Pfizer Investigational Site
    Sherbrooke, Quebec J1H 1Z1, Canada
  • Pfizer Investigational Site
    St Jerome, Quebec J7Z 5T3, Canada
  • Pfizer Investigational Site
    St-Georges Ouest, Quebec G5Y 4W1, Canada
  • Pfizer Investigational Site
    St-Marc Des Carrieres, Quebec G0A 4B0, Canada
  • Pfizer Investigational Site
    St. Lambert, Quebec J4P 2H4, Canada
  • Pfizer Investigational Site
    Ste-foy, Quebec G1V 4G2, Canada
  • Pfizer Investigational Site
    Regina, Saskatchewan S4P 3X3, Canada
  • Pfizer Investigational Site
    Quebec, G1J 1Z4, Canada
  • Pfizer Investigational Site
    Quebec, G1J 1Z6, Canada
  • Pfizer Investigational Site
    Quebec, G1S 2L6, Canada
  • Pfizer Investigational Site
    Rimouski, G5L 9A8, Canada
  • Pfizer Investigational Site
    St-Gedeon Beauce, G0M 1T0, Canada
  • Pfizer Investigational Site
    St. John's, A1A 2E2, Canada
  • Pfizer Investigational Site
    St. John's, A1A 3R5, Canada
  • Pfizer Investigational Site
    St. John's, A1B 3E4, Canada
  • Pfizer Investigational Site
    Ayr, Ayrshire KA7 1BG, United Kingdom
  • Pfizer Investigational Site
    Sandy, Bedfordshire SG19 3JR, United Kingdom
  • Pfizer Investigational Site
    Peterborough, Cambs PE7 3JL, United Kingdom
  • Pfizer Investigational Site
    Thornhill, Cardiff CF14 9BB, United Kingdom
  • Pfizer Investigational Site
    Fowey, Cornwall PL23 1DT, United Kingdom
  • Pfizer Investigational Site
    Darlington, County Durham DL16 6QA, United Kingdom
  • Pfizer Investigational Site
    Darlington, County Durham DL3 8SQ, United Kingdom
  • Pfizer Investigational Site
    Paignton, Devon TQ4 5LA, United Kingdom
  • Pfizer Investigational Site
    Plymouth, Devon PL5 3PY, United Kingdom
  • Pfizer Investigational Site
    Bournemouth, Dorset BH8 9EW, United Kingdom
  • Pfizer Investigational Site
    Angus, Dundee DD1 5LA, United Kingdom
  • Pfizer Investigational Site
    Central Milton Keyne, England MK9 2NR, United Kingdom
  • Pfizer Investigational Site
    Lancaster, England LA1 2LG, United Kingdom
  • Pfizer Investigational Site
    Surrey, England CR7 7JN, United Kingdom
  • Pfizer Investigational Site
    Wishaw, Lanarkshire, England ML2 7BG, United Kingdom
  • Pfizer Investigational Site
    Leigh-on-sea, Essex SS9 2UW, United Kingdom
  • Pfizer Investigational Site
    nEWPORT, gWENT NP18 1AZ, United Kingdom
  • Pfizer Investigational Site
    Letchworth, Hertfordshire SG6 4UB, United Kingdom
  • Pfizer Investigational Site
    Canterbury, Kent CT1 3NG, United Kingdom
  • Pfizer Investigational Site
    Whitstable, Kent CT5 1BZ, United Kingdom
  • Pfizer Investigational Site
    Blackpool, Lancashire FY4 3AD, United Kingdom
  • Pfizer Investigational Site
    Spalding, Lincolnshire PE11 2BH, United Kingdom
  • Pfizer Investigational Site
    Bangor, Belfast, Northern Ireland BT19 1PP, United Kingdom
  • Pfizer Investigational Site
    Coatbridge, Scotland ML5 3EE, United Kingdom
  • Pfizer Investigational Site
    Glasgow, Scotland G31 1QW, United Kingdom
  • Pfizer Investigational Site
    Frome, Somerset BA11 1EZ, United Kingdom
  • Pfizer Investigational Site
    Stairfoot, Barnsley, South Yorkshire S70 3RJ, United Kingdom

Showing the first 100 of 126 sites across 2 countries. Choose a country and city above to see the rest.

08

References and documents

Publications

  • Richard Hobbs FD, Gensini G, John Mancini GB, Manolis AJ, Bauer B, Genest J, Feldman RD, Harvey P, Jenssen TG, da Silva PM; JEWEL Study Group. International open-label studies to assess the efficacy and safety of single-pill amlodipine/atorvastatin in attaining blood pressure and lipid targets recommended by country-specific guidelines: the JEWEL programme. Eur J Cardiovasc Prev Rehabil. 2009 Aug;16(4):472-80. doi: 10.1097/HJR.0b013e32832b63f5. PubMed 19407658 ↗
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Oct 2004 and a completion of Sep 2005. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 28, 2006
First posted
May 29, 2006
Start
Oct 2004
Completion
Sep 2005
Last update
Jan 27, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
No changes since tracking began. The registry record was last updated on Jan 27, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00330785
First posted
May 29, 2006
Start date
Oct 2004
Completion
Sep 2005
Last update
Jan 27, 2021

Study contacts

Pfizer CT.gov Call Center
study director · Pfizer
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Amlodipine · Atorvastatin

Start the discussion